Clinical Trial Update: Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating quinacrine in androgen-independent prostate cancer has completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Quinacrine (quinacrine)

Snippet

Sponsor: Cleveland BioLabs | Conditions: Prostatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-04-11